Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bionoid Pharma Inc (OP: BINP )

0.3500 +0.1500 (+75.00%)
Streaming Delayed Price Updated: 9:40 AM EST, Nov 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 100
Open 0.3500
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.2000
Today's Range 0.3500 - 0.3500
52wk Range 0.0500 - 1.030
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The End of SDRs? AI Maverick Sales Automation, One Touchpoint at a Time
Via ACCESSWIRE
Bionoid Pharma, Inc. Launches Enhanced Supplements Ltd. to Drive Strategic E-Commerce Expansion
Via ACCESSWIRE

Performance

YTD
-46.15%
-46.15%
1 Month
+250.00%
+250.00%
3 Month
+16.67%
+16.67%
6 Month
+40.00%
+40.00%
1 Year
-65.00%
-65.00%

More News

Read More
Bionoid Pharma, Inc. Signs Binding Letter of Intent to Acquire Main E-Commerce Platform of Your Supplement Supply Store Ltd.
Via ACCESSWIRE
Bionoid Pharma, Inc. Engages Olayinka Oyebola & Co. as PCAOB External Auditor for Annual Financial Audit
Via ACCESSWIRE
Bionoid Pharma, Inc. Unveils Five-Year Strategic Roadmap
Via ACCESSWIRE
Bionoid Pharma, Inc. Acquires AI Maverick Intel
Via ACCESSWIRE
Bionoid Pharma Inc. Provides Update on Binding Letter of Intent to Acquire Global Alerts Corp.
Via ACCESSWIRE
Bionoid Pharma Signs Exclusive License Agreement with Global Alerts Corp.
Via ACCESSWIRE
Bionoid Pharma Extends Letter of Intent to Acquire Global Alerts Corp.
Via ACCESSWIRE
Bionoid Pharma Announces Agreement to Acquire AiMaverickIntel.com
Via ACCESSWIRE
Bionoid Pharma Announces Letter of Intent to Acquire Global Alerts Corp.
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.